Depressant and anticonvulsant effect of methanol extract of Swietenia mahagoni in mice

Indian Journal of Pharmaceutical Education and Research

Volumn 44, Issue 3, 2010, Pages 283-287

  Panda, Siva P ^a   Bera, S ^a   Naskar, S ^a   Adhikary, S ^b   Kandar, C C ^b   Haldar, P K ^a  

^a JADAVPUR UNIVERSITY   (India)

^b Institute of Pharmacy Jalpaiguri   (India)

Author keywords

Anticonvulsant; Pentobarbitone; Pentylenetetrazole; Strychnine; Swietenia mahagoni

Indexed keywords

DIAZEPAM; HERBACEOUS AGENT; METHANOL; PENTETRAZOLE; PENTOBARBITAL; STRYCHNINE; SWIETENIA MAHAGONI EXTRACT; UNCLASSIFIED DRUG;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; BARK; CENTRAL NERVOUS SYSTEM DEPRESSION; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; MALE; MELIACEAE; MOUSE; NONHUMAN; SLEEP TIME; SWIETENIA MAHAGONI; TONIC SEIZURE; TREATMENT OUTCOME;

EID: 77957334965     PISSN: 00195464     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. McNamara JO. Drugs effective in the treatment of the epilepsies. In: Goodman and Gillman's The Pharmacological Basis of Therapeutics. 9 th ed. New York: Hardman JG, Limbird JE, Molinoff PB, Ruddon RW and Gillman AG; McGraw Hill; 1996; 461-86.
2. World Health Organization. WHO Guideline for the Assessment of herbal Medicines, WHO expert committee on specification for pharmaceutical preparation. 1996; Technical Report series No 863. Geneva.
3. Li DD, Chen JH, Chen Q, Li GW, Chen j, Yue jm, Chen ML, Wang XP, Shen JH, Shen X, Jiang HL. Swietenia mahagoni extract shows agonistic activity to PPAR (gamma) and gives ameliorative effects on diabetic db/db mice. Acta Pharmacol Sin. 2005; 26 (2):220-222.
4. Pullaiah T. Encyclopedia of World medicinal plants.4 th ed. New Delhi, India: Regency Publications; 2006; p 1881.
5. Kadota S, Marpaaung L, Kikuchi T, Ekimoto H. Constituents of the seeds of Swietenia mahagoni JACQ. III. Structures of mahonin and secomahoganin. Chem Pharm Bull. 1990; 38: 1495-500.
6. Khare CP. Indian medicinal plants: An Illustrated Dictionary, New Delhi, India: Springer Science. 2007; p 634.
7. Miroslav MG. Elsevier's dictionary of trees.1st ed. 2005; p 880.
8. Tripathi KD. Essentials of Medical Pharmacology. 4 th ed. New Delhi, India: Jaypee Brothers Medical Publishers (p) Ltd; 1999; 382-477.
9. Kulkarni SK. Hand Book of Experimental Pharmacology. 3 rd ed. New Delhi, India: Vallabh Prakashan; 1999; 115-133.
10. Bum NE, Schmutz M, Meyer C, Rakotonirina A, Bopelet M, Portet C, Jeker A, Rakotonirina SV, Olpe HR and Herrling P. Anticonvulsant properties of the methanolic extract of Cyperus articulatus (Cyperaceae). Journal of Ethnopharmacology 2001; 76: 145-150.
11. Vogel HG and Vogel WH. Drug discovery and evaluation. Berlin Heidelberg, New York: Springer-Verlag; 1997; 26.
12. Loscher W and Schmidt D. Which animal models should be used in the search for new antiepileptic drugs? A proposal based on experimental and clinical considerations. Epilepsy Res. 1988; 2:145-181.
13. Du XM, Sun NY, Takizawa N, Guo YT and Shoyama Y. Sedative and anticonvulsant activities of goodyerin, a flavonol glycoside from Goodyera schlechtendaliana. Phytother Res. 2002; 16: 261-263.
14. Griebel G, Perrault G, Tan S, Schoemaker H, Sanger D. Pharmacological studies on synthetic flavonoids: comparision with diazepam. Neuropharmacology 1999; 38: 965-977.
15. Salgueiro JB, Ardenghi P, Dias M, Ferreira MB, Izquierdo I and Medina JH. Anxiolytic natural and synthetic flavonoid ligands of the central benzodiazepine receptor have no effect on memory tasks in rats. Pharmacol Biochem Behav. 1997; 58: 887-891.
16. Librowski T, Czarnecki R, Mendyk A and Jastrzebska M. Influence of new monoterpene homologues of GABA on the central nervous system activity in mice. Pol J Pharmacol. 2000; 52: 317-321.